DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $127,000 | -93.5% | 44,002 | -86.8% | 0.00% | – |
| Q3 2016 | $1,967,000 | +107.7% | 334,603 | +6.0% | 0.00% | – |
| Q2 2016 | $947,000 | -72.8% | 315,722 | -51.5% | 0.00% | -100.0% |
| Q1 2016 | $3,488,000 | -54.5% | 650,704 | +0.8% | 0.00% | -50.0% |
| Q4 2015 | $7,662,000 | +137.7% | 645,510 | +64.4% | 0.00% | +100.0% |
| Q3 2015 | $3,224,000 | -41.8% | 392,716 | -1.1% | 0.00% | 0.0% |
| Q2 2015 | $5,541,000 | +119.6% | 397,184 | +278.3% | 0.00% | 0.0% |
| Q1 2015 | $2,523,000 | +48.5% | 104,989 | +1.7% | 0.00% | – |
| Q4 2014 | $1,699,000 | +50.9% | 103,184 | +16.6% | 0.00% | – |
| Q3 2014 | $1,126,000 | -43.2% | 88,469 | +0.6% | 0.00% | -100.0% |
| Q2 2014 | $1,984,000 | -27.3% | 87,901 | -9.0% | 0.00% | 0.0% |
| Q1 2014 | $2,730,000 | – | 96,624 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |